Amlodipine Besylate Price Trend

Amlodipine Besylate Prices December 2023

The price of amlodipine besylate in the United States for Q4 2023 reached 75,190 USD/MT in December. The United States witnessed challenges from inflation and high interest rates, resulting in a decrease in consumer confidence and a weakened demand for the product. However, there was a minor improvement in November, driven by a decrease in inflation and a rebound in consumer spending.

The price of amlodipine besylate in China for Q4 2023 reached 73,845 USD/MT (USP, FDA) in December. The market in China experienced a decline in prices due to lower demand and trade activity remained subdued.

The price of amlodipine besylate in Germany for Q4 2023 reached 74,672 USD/MT (USP, FDA) in December. The market in Germany witnessed a downfall in demand from end-user sectors, the country with the most substantial price changes. This deteriorating demand is due to persistent inflationary pressures caused by increasing food and energy costs, which have strained consumers’ purchasing power.

Amlodipine Besylate Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Amlodipine Besylate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of amlodipine besylate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of amlodipine besylate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of amlodipine besylate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing amlodipine besylate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Amlodipine Besylate Market Analysis

The global amlodipine besylate market size reached US$ 389.6 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 622.2 Million, at a projected CAGR of 5.30% during 2023-2032.

• The increasing prevalence of hypertension cases represents one of the key factors influencing the growth of the market across the globe. This is primarily attributed to the lifestyle changes, dietary factors, and aging population which are driving the market growth. According to the Centers for Disease Control and Prevention, in 2021, hypertension was a primary or contributing cause of 6,91,095 deaths in the United States. About one in four adults with hypertension have their hypertension under control (22.5%, 27.0 million). This is further supporting the demand for amlodipine besylate.
• The rising demand for managing high blood pressure is fueling the demand for amlodipine besylate as a primary medication. According to the Centers for Disease Control and Prevention, a greater percentage of men (50%) have high blood pressure than women (44%). High blood pressure is more common non-Hispanic black adults (56%) than in non-Hispanic white adults (48%), non-Hispanic Asian adults (46%), or Hispanic adults (39%).
• The market is also driven by the affordability of amlodipine besylate as compared to other hypertension medications. Moreover, the expiration of patents for branded versions of amlodipine besylate is leading to the emergence of generic drugs, which are cheaper and hence driving a broader market reach. According to IMS Health Institute, generic drugs saved the US healthcare system nearly $2.2 trillion from 2009 to 2019.
• The increasing awareness about hypertension and its risk, along with improved healthcare infrastructure, and more individuals seeking treatment are facilitating the growth of the market. According to World Health Organization (WHO), an estimated 1.28 billion adults aged 30 to 79 years across the globe have hypertension, most (two-third) living in low- and middle-income countries. An estimated 46% of adults with hypertension are unaware that they have the condition. Less than half of adults (42%) with hypertension are diagnosed and treated. Approximately, 1 in five adults (21%) with hypertension have it under control.

Amlodipine Besylate News

The report covers the latest developments, updates, and trends impacting the global amlodipine besylate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in amlodipine besylate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the amlodipine besylate price trend.

Latest developments in the amlodipine besylate industry:

• In February 2024, Dr. Reddy’s Laboratories announced that they received a Voluntary Action Indicated (VAI) status from the United States Food and Drug Administration (USFDA) following an inspection of its research and development (R&D) centres for Integrated Product Development Organisation (IPDO) in Bachupally, Hyderabad.
• In January 2024, Teva announced its intention to divest its active pharmaceutical ingredient (API) business, or “TAPI”. TAPI is a global leader in the small molecule API industry, with approximately 4,300 employees worldwide.

Product Description

Amlodipine besylate refers to a prescription medication excessively utilized in the management of high blood pressure (hypertension) and certain types of chest pain such as angina.

Amlodipine besylate belongs to the class of drugs known as calcium channel blockers. It works by relaxing and widening blood vessels, which improves blood flow and makes it easier for the heart to pump blood. This mechanism not only aids in reducing blood pressure level but also prevents heart attacks, strokes, and kidney problems.

Amlodipine besylate is also administered orally, and its dosages vary based on the condition being treated, patient response, and other medications being taken. While it is generally well tolerated, potential side effects such as swelling, fatigue, and dizziness. Patients are advised to consult their healthcare provider before starting or making any changes to their medication regimen to ensure it's safe and effective for their specific health conditions.

Regional Coverage

The report provides a detailed analysis of the amlodipine besylate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the amlodipine besylate price trend.

Global Amlodipine Besylate Price

The report offers a holistic view of the global amlodipine besylate pricing trends in the form of amlodipine besylate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of amlodipine besylate but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed amlodipine besylate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Amlodipine Besylate Price

During the fourth quarter of 2023, the European region in the amlodipine besylate market experienced a downfall price with curtailed market demand due to the implementation of higher interest rates by the European Central Bank (ECB). Moreover, high inflation and the ample availability of supply in the market contributed to the decline in the prices. Market providers lowered prices to clear out their inventories, as warehouses had sufficient stock.

This analysis can be extended to include detailed amlodipine besylate price information for a comprehensive list of countries.

North America Amlodipine Besylate Price

During the fourth quarter of 2023, the amlodipine besylate market in the North American region witnessed a bearish trend attributed to persistent inflation and historically high interest rates, which further led to diminished consumer confidence and a decline in demand. In addition to this, the market experienced no significant percentage change in the prices compared to the previous year’s fourth quarter.

Specific amlodipine besylate historical data within the United States and Canada can also be provided.

Middle East and Africa Amlodipine Besylate Price

The report explores the amlodipine besylate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on amlodipine besylate prices for countries can also be provided.

Asia Pacific Amlodipine Besylate Price

During the fourth quarter in 2023, the amlodipine besylate pricing in the Asia Pacific region witnessed an over stability with a moderate to high supply of amlodipine besylate available. In line with this, the weak demand, ample supply, and fluctuations in the manufacturing sector, especially in China which is leading to fluctuations in prices and market in the Asia Pacific region.

This amlodipine besylate price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Amlodipine Besylate Price

The analysis of amlodipine besylate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of amlodipine besylate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting amlodipine besylate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The amlodipine besylate price charts ensure our clients remain at the forefront of the industry.